Sun Pharma acquires Canada's Aquinox Pharma for $8.2M
Sun Pharma has acquired Canada-based Aquinox Pharmaceuticals for $8.2 million through its subsidiary Taro, according to an NDTV report.
Aquinox is a research and development company focused on commercializing pharmaceutical products.
The acquisition comes after the Canadian company’s parent, Aquinox Pharmaceuticals merged with Neoleukin Therapeutics in August last year.
Prior to the merger, Aquinox focused on discovering and developing novel therapeutics for conditions marked by inflammation, inflammatory pain, and blood cancers.